Evidence map›Paper›PMID 35795489›Full record

ReviewPulmonary circulation2022

Recognizing pulmonary hypertension following pulmonary thromboendarterectomy: A practical guide for clinicians.

Paul Forfia, Bruce Ferraro, Anjali Vaidya

Open access · goldAbstract readReview
In one paragraph

Review in Pulmonary circulation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Paul ForfiaPulmonary Hypertension, Right Heart Failure, and CTEPH Program, Heart and Vascular Institute, Temple University Hospital Temple University Lewis Katz School of Medicine Philadelphia Pennsylvania USA.
Bruce FerraroPulmonary Hypertension, Right Heart Failure, and CTEPH Program, Heart and Vascular Institute, Temple University Hospital Temple University Lewis Katz School of Medicine Philadelphia Pennsylvania USA.
Anjali VaidyaPulmonary Hypertension, Right Heart Failure, and CTEPH Program, Heart and Vascular Institute, Temple University Hospital Temple University Lewis Katz School of Medicine Philadelphia Pennsylvania USA.
Temple University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic thromboembolic pulmonary hypertension (CTEPH) is a form of pulmonary hypertension (PH) arising from pulmonary vascular obstruction at varying levels within the pulmonary vascular bed, due to chronic pulmonary emboli. The cornerstone of treatment for CTEPH is pulmonary thromboendarterectomy (PTE), a specialized surgery to remove the chronic vascular obstruction. At experienced centers, PTE leads to marked hemodynamic improvement and, in many cases, normalization of cardiopulmonary hemodynamics. However, increasing evidence supports the fact that a significant percentage of patients will have persistent PH after PTE. No consensus exists on the optimal approach to post-PTE patient assessment, and often the most experienced CTEPH centers have little experience in the direct follow-up care of the CTEPH patient post PTE. In this article, we will discuss a

Indexed as

chronic thromboembolic pulmonary hypertensionCTEPHpulmonary arterial hypertensionright heart failure

Identifiers

PMID35795489
PMCPMC9248789
OpenAlexW4224284139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.